<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">BMC Vet. Res</journal-id><journal-title-group><journal-title>BMC Veterinary Research</journal-title></journal-title-group><issn pub-type="epub">1746-6148</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5465460</article-id><article-id pub-id-type="publisher-id">1053</article-id><article-id pub-id-type="doi">10.1186/s12917-017-1053-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Omental adipose tissue is a more suitable source of canine Mesenchymal stem cells</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bahamondes</surname><given-names>Francisca</given-names></name><address><email>fbahamondesg@ug.uchile.cl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Flores</surname><given-names>Estefania</given-names></name><address><email>eflores@u.uchile.cl</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cattaneo</surname><given-names>Gino</given-names></name><address><email>gcatanne@uchile.cl</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bruna</surname><given-names>Flavia</given-names></name><address><email>flabruna@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Conget</surname><given-names>Paulette</given-names></name><address><email>pconget@udd.cl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Centro de Medicina Regenerativa, Facultad de Medicina, Cl&#x000ed;nica Alemana - Universidad del Desarrollo, Av. Las Condes 12,438, Lo Barnechea, Santiago, 7710162 Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Departamento de Ciencias Cl&#x000ed;nicas, Facultad de Ciencias Veterinarias y Pecuarias, </institution><institution>Universidad de Chile, </institution></institution-wrap>Av. Santa Rosa 11,735, Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>13</volume><elocation-id>166</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>8</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Mesenchymal Stem Cells (MSCs) are a promising therapeutic tool in veterinary medicine. Currently the subcutaneous adipose tissue is the leading source of MSCs in dogs. MSCs derived from distinct fat depots have shown dissimilarities in their accessibility and therapeutic potential. The aims of our work were to determine the suitability of omental adipose tissue as a source of MSCs, according to sampling success, cell yield and paracrine properties of isolated cells, and compared to subcutaneous adipose tissue.</p></sec><sec><title>Results</title><p>While sampling success of omental adipose tissue was 100% (14 collections from14 donors) for subcutaneous adipose tissue it was 71% (10 collections from 14 donors). MSCs could be isolated from both sources. Cell yield was significantly higher for omental than for subcutaneous adipose tissue (38&#x000a0;&#x000b1;&#x000a0;1 vs. 30&#x000a0;&#x000b1;&#x000a0;1&#x000a0;CFU-F/g tissue, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.0001). No differences were observed between sources regarding cell proliferation potential (73&#x000a0;&#x000b1;&#x000a0;1 vs. 74&#x000a0;&#x000b1;&#x000a0;1 CDPL) and cell senescence (at passage 10, both cultures presented enlarged cells with cytoplasmic vacuoles and cellular debris). Omental- and subcutaneous-derived MSCs expressed at the same level bFGF, PDGF, HGF, VEGF, ANG1 and IL-10. Irrespective of the source, isolated MSCs induced proliferation, migration and vascularization of target cells, and inhibited the activation of T lymphocytes.</p></sec><sec><title>Conclusion</title><p>Compared to subcutaneous adipose tissue, omental adipose tissue is a more suitable source of MSCs in dogs. Since it can be procured from donors with any body condition, its collection procedure is always feasible, its cell yield is high and the MSCs isolated from it have desirable differentiation and paracrine potentials.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12917-017-1053-0) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Mesenchymal stem cell</kwd><kwd>Source</kwd><kwd>Adipose tissue</kwd><kwd>Omentum</kwd><kwd>Canine</kwd><kwd>Dog</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002848</institution-id><institution>Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica</institution></institution-wrap></funding-source><award-id>21110863</award-id><award-id>Doctorado Nacional</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Mesenchymal stem cells (MSCs) are non-hematopoietic precursor cells that can be differentiated, among others, into chondrocytes, osteocytes and adipocytes [<xref ref-type="bibr" rid="CR1">1</xref>]. Together, MSCs secrete trophic, vasculogenic and immunomodulatory factors that have a paracrine effect on tissue resident cells [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. Hence, MSCs are a promissory therapeutic tool for regenerative medicine [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p>The leading source of MSCs is the bone marrow. In 2001, they were isolated for the first time from adipose tissue [<xref ref-type="bibr" rid="CR6">6</xref>]. When compared to bone marrow, adipose tissue appeared as a superior source of MSCs due to the fact that a less invasive procedure is required to procure it [<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>].</p><p>In veterinary medicine, it has been proven that the administration of adipose-derived MSCs have therapeutic effects in small animal patients, particularly in cats and dogs [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. Adult dogs have adipose tissue locates mainly in subcutaneous and visceral depots. Thus, adipose tissue may be procured through minimally invasive procedures from arms, thighs and abdomen (subcutaneous), or from omentum, kidney and liver (visceral) [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. While the abundance of subcutaneous adipose tissue depends on the body condition, the extent of omentum is relatively constant [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. It has been demonstrated that there are MSCs in the omentum of both dogs [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and humans [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Omental-derived MSCs are similar to subcutaneous-derived MSCs according to their proliferation and surface antigen expression [<xref ref-type="bibr" rid="CR18">18</xref>]. Up to our knowledge, no data are available regarding the abundance and paracrine potential of omental-derived MSCs. Since previous studies showed that adipose-derived MSC properties vary from depot to depot [<xref ref-type="bibr" rid="CR21">21</xref>], it will be also interesting to compare MSCs isolated form omentum with those isolated from subcutaneous fat, the leading adipose source of MSCs.</p><p>The aims of our work were to determine the suitability of omental adipose tissue as a source of MSCs, according to sampling success, cell yield and paracrine properties of isolated cells, and compared to subcutaneous adipose tissue.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Collection of adipose tissue</title><p>Fourteen female dogs of different breeds, 6&#x02013;12&#x000a0;months old, with normal corporal condition, clinically healthy and having elective ovariohysterectomies were enrolled in the study, after client-owned provided written informed consent. Animals were pre-anesthetized with 0.04&#x000a0;mg/Kg Acepromazine (Holliday<italic>-</italic>Scott S.A, Buenos Aires, Argentina). General anesthesia was induced with 3&#x000a0;mg/Kg Propofol (Fresenius Kabi, Spain) and maintained with Isofluorane (Baxter Healthcare Corporation<italic>,</italic> Deerfield, IL). Approximately 3cm<sup>3</sup> (5-10&#x000a0;g) of omental and subcutaneous adipose tissue were procured from greater omentum and abdominal region, respectively. Subsequently, an ovariohysterectomy was performed. Muscular and skin incisions were sutured with a simple, interrupted pattern. Up to three days post-surgery animals received 1&#x000a0;mg/Kg/24&#x000a0;h Ketoprofen (Merial Laboratorios, Argentina).</p><p>Study was approved by Ethic Committee Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile (No. 03&#x02013;2014).</p></sec><sec id="Sec4"><title>Isolation, ex vivo expansion and characterization of MSCs</title><p>Adipose tissue samples were weighed, washed with phosphate buffered saline (PBS. Sigma, St. Louis, MO, USA) containing 80 &#x003bc;g/mL gentamycin (Sanderson Laboratory, Santiago, Chile), minced with scissors and scalpels, and digested in PBS containing 1&#x000a0;mg/mL collagenase type II (Gibco, Grand Island, NY, USA), at 37&#x000a0;&#x000b0;C, overnight. Enzyme activity was neutralized with alpha-MEM (Gibco, Auckland, NZ) supplemented with 10% fetal bovine serum (Gibco, Auckland, NZ) and 80 &#x003bc;g/mL gentamicin (Sanderson Laboratory, Santiago, Chile) (here after expansion medium), and centrifuged at 400&#x000d7;g for 10&#x000a0;min. Pelleted cells were resuspended in expansion medium and plated at a density of 50,000 nucleated cells/cm<sup>2</sup> and cultured under an atmosphere with 5% CO<sub>2</sub>, at 37&#x000a0;&#x000b0;C. Fourty eight hours later, nonadherent cells were removed by media change. When 80% confluence was achieved, adherent cells were detached with 0.25% trypsin and 2.65&#x000a0;mM EDTA, centrifuged and subcultured at 5000 cells/cm<sup>2</sup>. After two subcultures, adherent cells were characterized according to their adipogenic [<xref ref-type="bibr" rid="CR21">21</xref>], chondrogenic [<xref ref-type="bibr" rid="CR22">22</xref>] and osteogenic differentiation potential [<xref ref-type="bibr" rid="CR23">23</xref>]. Although there are currently no consensus markers for canine MSCs as there are for human MSCs [<xref ref-type="bibr" rid="CR1">1</xref>], immunophenotyping was performed by flow cytometry analysis after labeling with monoclonal antibodies against: CD45<sup>FITC</sup>, CD11b<sup>PE-Cy5</sup>, CD44<sup>APC</sup> and CD90<sup>PE</sup> or their respective isotype controls (rat IgG2b<sup>FITC</sup>, rat IgG2b<sup>PE-Cy5</sup>, rat IgG2b<sup>APC</sup> or rat IgG2b<sup>PE</sup>; eBioscience, San Diego, CA).</p></sec><sec id="Sec5"><title>Fibroblast-like Colony forming unit (CFU-F) assay</title><p>CFU-F assay was performed on freshly isolated cells as previously described [<xref ref-type="bibr" rid="CR24">24</xref>]. Briefly, 500 mononuclear cells/cm<sup>2</sup> were cultured in expansion medium. At day 7, cells were fixed with 4% paraformaldehyde for 10&#x000a0;min and stained with 0.5% crystal violet (Sigma-Aldrich, St. Louis, MO) in 10% methanol for 20&#x000a0;min. Plates were observed under light microscope (Leica DM2000). Clusters containing more than 50 cells were scored as CFU-Fs and counted. Results were expressed as CFU-F per gram of tissue (CFU-F/g tissue).</p><p>Assays were performed in triplicate.</p></sec><sec id="Sec6"><title>Evaluation of cumulative population doubling level (CPDL) and senescence</title><p>One thousand cells/cm<sup>2</sup> were seeded and cultured with expansion medium. The medium was changed every three days and cells were subcultured when reaching 80% confluence. The population doubling (PD) at each subculture was calculated according to the formula PD&#x000a0;=&#x000a0;ln (<italic>N</italic>
<sub><italic>f</italic></sub>
<italic>/N</italic>
<sub><italic>i</italic></sub>) /ln 2, where <italic>N</italic>
<sub><italic>i</italic></sub> and <italic>N</italic>
<sub><italic>f</italic></sub> are initial and final cell numbers, respectively. The PDs of continuous subcultures were added to obtain CPDL [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>Senescence was assessed looking for changes in cell morphology such as cell enlargement, accumulation of vacuoles and presence of cellular debris [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p>Assays were performed in triplicate.</p></sec><sec id="Sec7"><title>RT-qPCR</title><p>RNA was extracted from cells using Tryzol (<italic>Invitrogen</italic>, Carlsbad, CA, USA) and treated with DNAse (<italic>Invitrogen</italic>, Carlsbad, CA, USA) following the manufacturer&#x02019;s instructions. One &#x003bc;g of RNA was reverse-transcribed using oligo-dT primers and Moloney murine leukemia virus reverse transcriptase. The abundance of mRNA was determined by qPCR using SYBR Green Technology and canine-specific primers for bFGF, PDGF HGF, VEGF, ANG1, IDO, IL-10 and 18S (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Cycling condition were: 1&#x000a0;cycle, 94&#x000a0;&#x000b0;C for 10&#x000a0;min; 30&#x02013;35&#x000a0;cycles, 94&#x000a0;&#x000b0;C for 10&#x000a0;min; optimal annealing temperature for 5&#x000a0;min; 72&#x000a0;&#x000b0;C for 4&#x000a0;min; 1&#x000a0;cycle, 64&#x000a0;&#x000b0;C for 10&#x000a0;min; 1&#x000a0;cycle, 40&#x000a0;&#x000b0;C for 30&#x000a0;min. The qPCR products were separated by electrophoresis on 2% agarose gel, stained with 1% ethidium bromide and visualized under UV light. Digital images were captured with Alpha imagen software. Values were normalized to 18S mRNA levels. Relative gene expression was quantified with the 2 <sup>-&#x00394;&#x00394;Ct</sup> method [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec8"><title>Proliferation assay</title><p>Human fibroblasts were seeded at 4000 cells/cm<sup>2</sup> and cultivated with alpha-MEM (control) or alpha-MEM conditioned by MSCs for 24&#x000a0;h. The medium was changed every 3&#x000a0;days. Three, six, nine and 12&#x000a0;days later, cells were stained with 0.5% crystal violet in 10% methanol for 20&#x000a0;min. After four washes, crystal violet incorporated into the cells were solubilized with 50% methanol in PBS and quantified spectrophotometrically (absorbance at 570&#x000a0;nm) [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p>Assays were performed in triplicate.</p></sec><sec id="Sec9"><title>Scratch assay</title><p>Human fibroblasts were seeded at 8000 cells/cm<sup>2</sup>. After 24&#x000a0;h, a line in the monolayer was performed with a sterile p200 pipette tip and medium was changed by alpha-MEM (control) or alpha-MEM conditioned by MSCs for 24&#x000a0;h. Zero, six, and 12&#x000a0;h after scratching images were captured under a light microscope (Leica DM2000) with a digital camera (Leica DFC 295). Image J software (<ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</ext-link>) was used to quantify the scratch area [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p>Assays were performed in triplicate.</p></sec><sec id="Sec10"><title>Tube formation assay</title><p>Human umbilical vein endothelial cells (HUVECs) were seeded at 3000 cells/cm<sup>2</sup> on 10&#x000a0;mg/mL growth factor-reduced Matrigel (BD Biosciences, Boston, MA, USA) and exposed to alpha-MEM (control), alpha-MEM conditioned by MSCs for 24&#x000a0;h or endothelial growth medium (Lonza, Walkersville, MD, USA) (positive control) [<xref ref-type="bibr" rid="CR28">28</xref>]. Five hours later, images were captured under a light microscope using a digital camera. WimTube program (Wimasis GmbH, Munich, Germany) was used to quantify i) total tube length, ii) total branching point, iii) total loops.</p><p>Assays were performed in triplicate.</p></sec><sec id="Sec11"><title>T lymphocyte proliferation assay</title><p>Canine peripheral blood mononuclear cells were labeled with carboxyfluorescein succinimidyl ester (Invitrogen/Molecular Probes, Eugene, OR) and cultivated with alpha-MEM (control) or alpha-MEM conditioned by MSCs for 24&#x000a0;h, supplemented with 4 uL (1:10) phytohaemaglutinin (Gibco, Invitrogen, Corporation, Scotland, UK). Five days later, cells were stained with monoclonal antibody against CD4<sup>PE</sup> (Serotec, Kidlington, Oxford, United Kingdom) and analyzed by flow cytometry [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p>Assays were performed in triplicate.</p></sec><sec id="Sec12"><title>Statistical analysis</title><p>Data are presented as mean&#x000a0;&#x000b1;&#x000a0;S.E.M. To determine the statistical significance of intergroup differences a one-way ANOVA test was used to compare mean values among all groups and Student&#x02019;s unpaired <italic>t</italic>-test or Mann-Whitney test (non parametric) was used to compare mean values between two groups. <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 was considered as statistically significant.</p></sec></sec><sec id="Sec13"><title>Results</title><sec id="Sec14"><title>Omental adipose tissue has higher sampling success than subcutaneous adipose tissue</title><p>The age and weight of donor dogs were 10&#x000a0;&#x000b1;&#x000a0;3&#x000a0;months and 12&#x000a0;&#x000b1;&#x000a0;6 Kg (Table <xref rid="Tab1" ref-type="table">1</xref>). Omental samples were procured from the 14 donors and subcutaneous samples were procured from 10 of them. Thus, the success sampling rates were 100% (14 of 14) for omental adipose tissue and 71% (10 of 14) for subcutaneous adipose tissue (Table <xref rid="Tab1" ref-type="table">1</xref>). The average weight of the procured samples was 5.2&#x000a0;&#x000b1;&#x000a0;4.5&#x000a0;g for omental and 2.4&#x000a0;&#x000b1;&#x000a0;3.4&#x000a0;g for subcutaneal adipose tissue (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Enrolled animals and procured samples characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Donor (identifier)</th><th>Age (months)</th><th>Weight (kilograms)</th><th>Subcutaneous (grams)</th><th>Omental (grams)</th></tr></thead><tbody><tr><td>B001</td><td>8</td><td>8</td><td>not available</td><td>6.3</td></tr><tr><td>P002</td><td>12</td><td>15</td><td>4.8</td><td>8.1</td></tr><tr><td>L003</td><td>7</td><td>11</td><td>4.6</td><td>9.8</td></tr><tr><td>P004</td><td>8</td><td>12</td><td>not available</td><td>3.1</td></tr><tr><td>K005</td><td>12</td><td>15</td><td>1.9</td><td>2.3</td></tr><tr><td>L006</td><td>7</td><td>12</td><td>4.5</td><td>8.4</td></tr><tr><td>P007</td><td>8</td><td>10</td><td>3.2</td><td>4.5</td></tr><tr><td>C008</td><td>12</td><td>16</td><td>3.1</td><td>7.1</td></tr><tr><td>C009</td><td>11</td><td>6</td><td>not available</td><td>3.2</td></tr><tr><td>S010</td><td>8</td><td>15</td><td>5.8</td><td>5.9</td></tr><tr><td>O011</td><td>8</td><td>7</td><td>not available</td><td>3.7</td></tr><tr><td>C012</td><td>12</td><td>10</td><td>1.5</td><td>3.0</td></tr><tr><td>P013</td><td>10</td><td>6</td><td>2.3</td><td>4.8</td></tr><tr><td>S014</td><td>10</td><td>18</td><td>3.3</td><td>3.2</td></tr><tr><td>TOTAL</td><td>10&#x000a0;&#x000b1;&#x000a0;3</td><td>12&#x000a0;&#x000b1;&#x000a0;6</td><td>2.4&#x000a0;&#x000b1;&#x000a0;3.4</td><td>5.2&#x000a0;&#x000b1;&#x000a0;4.5</td></tr></tbody></table></table-wrap>
</p><p>Further characterization of adipose-derived MSCs was performed for samples obtained from the 10 donors in whom it was possible to obtain both omental and subcutaneous adipose tissues<bold>.</bold>
</p></sec><sec id="Sec15"><title>Omental adipose tissue and subcutaneous adipose tissue have MSCs</title><p>Cells isolated from both sources adhered to plastic and showed fibroblast-like morphology (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). Together, they were negative for hematopoietic markers (CD45 and CD11b) and positive for MSC markers (CD90 and CD44) (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). When exposed to adipogenic stimulus, cells differentiated into adipocytes that accumulate lipid droplets throughout the cytoplasm as confirmed by Oil Red O staining (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). After 21&#x000a0;days under chondrogenic induction, sulfated glycosaminoglycans were present in the matrix as revealed by Safranin O staining (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). Cell osteogenic differentiation was confirmed due to the appearance, 3 weeks after exposure to osteogenic medium, of calcium deposits that stained with Alizarin Red (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Omental adipose tissue and subcutaneous adipose tissue have MSCs. <bold>a</bold> Representative photomicrographs of primary culture of subcutaneous- and omental-derived cells. <bold>b</bold> Flow cytometry analysis after immunostaining with monoclonal antibodies against CD45, CD11b, CD90 and CD44 (<italic>green lines</italic>) or isotype controls (<italic>red lines</italic>). <bold>c</bold> Representative photomicrographs of MSCs stained with Oil Red O (adipogenesis), Safranin O (chondrogenesis) or Alizarin Red (osteogenesis) 3 weeks after differentiation induction. Control undifferentiated cells are also shown. Abbreviations: SC: subcutaneous adipose tissue; OM: omental adipose tissue</p></caption><graphic xlink:href="12917_2017_1053_Fig1_HTML" id="MO1"/></fig>
</p></sec><sec id="Sec16"><title>Omental adipose tissue has higher abundance of MSCs than subcutaneous adipose tissue</title><p>The relative abundance of MSCs in omental adipose tissue was 38&#x000a0;&#x000b1;&#x000a0;1&#x000a0;CFU-F/g tissue and in subcutaneous adipose tissue was 30&#x000a0;&#x000b1;&#x000a0;1&#x000a0;CFU-F/g tissue, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.0001 (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>-<xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Omental adipose tissue has higher abundance of MSCs than subcutaneous adipose tissue. <bold>a</bold> Quantitative analysis of CFU-Fs per gram of tissue sampled. <bold>b</bold> Representative photographs of plates stained with crystal violet 7&#x000a0;days after seeding of nucleated cells from tissue samples. <bold>c</bold> Quantitative analysis of CPDL up to passage 12. <bold>d</bold> Representative photomicrographs of S-MSCs and O-MSCs at passages 1 (P1) and 10 (P10). Abbreviations: SC: subcutaneous adipose tissue; OM: omental adipose tissue; CFU-F/g tissue: colony forming units per grams of tissue; S-MSCs: mesenchymal stem cells derived from subcutaneous adipose tissue; O-MSCs: mesenchymal stem cells derived from omental adipose tissue; CDPL: cumulative population doubling level</p></caption><graphic xlink:href="12917_2017_1053_Fig2_HTML" id="MO2"/></fig>
</p></sec><sec id="Sec17"><title>MSCs derived from omental and subcutaneous adipose tissues have a similar expansion potential</title><p>No statistical difference was observed bewteen omental- and subcutaneous-derived MSCs regarding their proliferation potential up to passage 12 (73&#x000a0;&#x000b1;&#x000a0;1 vs. 74&#x000a0;&#x000b1;&#x000a0;1 CDPL) (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>). Senescence characteristics such as cell enlargement, generation of vacuoles and presence of cellular debris were seen from passage 10 in both MSCs (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>).</p></sec><sec id="Sec18"><title>MSCs derived from omental and subcutaneous adipose tissues have similar trophic properties</title><p>Both adipose-derived MSCs expressed at the same level the trophic factors bFGF, PDGF and HGF (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). Accordingly, no differences were observed in their potential to promote human fibroblast proliferation and migration (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>, c and d).<fig id="Fig3"><label>Fig. 3</label><caption><p>MSCs derived from omental and subcutaneous adipose tissues have similar trophic properties. <bold>a</bold> Quantitative analysis of mRNA levels of trophic factors. <bold>b</bold> Quantitative analysis of proliferation kinetic of human fibroblast cultivated with S-MSCs CM or O-MSCs CM evaluated during 12&#x000a0;days. <bold>c</bold> Representative photomicrographs of invaded area at 0 (T0), six (T6) and 12 (T12) hours post exposure to CMs. <bold>d</bold> Quantitative analysis of invaded area evaluated as the percentage of area free of cells at 6 or 12&#x000a0;h post exposure to CM with respect to 0&#x000a0;h. Abbreviations: S-MSCs: mesenchymal stem cells derived from subcutaneous adipose tissue; O-MSCs: mesenchymal stem cells derived from omental adipose tissue; CM: conditioned medium; <bold>bFGF</bold>: basic fibroblast growth factor; <bold>PDGF</bold>: platelet-derived growth factor; <bold>HGF</bold>: hepatocyte growth factor</p></caption><graphic xlink:href="12917_2017_1053_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec19"><title>MSCs derived from omental and subcutaneous adipose tissues have similar vasculogenic properties</title><p>Irrespective of their origin, adipose-derived MSCs expressed VEGF and ANG1 (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). Consequently, they equally promote tube formation of HUVEC (total tube length, total branching point and total loops) (Fig. <xref rid="Fig4" ref-type="fig">4b and c</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>MSCs derived from omental and subcutaneous adipose tissues have similar vasculogenic properties. <bold>a</bold> Quantitative analysis of mRNAs levels of vasculogenic factors. <bold>b</bold> Representative photomicrographs of tube assay performed with 3D collagen-embedded human umbilical endothelial cells cultivated 5&#x000a0;h with S-MSCs CM or O-MSCs CM and analyzed by Wimasis software. <bold>c</bold> Quantitative analysis of total tube length, total branching point and total loops of tube assay among the different conditions. Abbreviations: S-MSCs: mesenchymal stem cells derived from subcutaneous adipose tissue; O-MSCs: mesenchymal stem cells derived from omental adipose tissue; CM: conditioned medium; <bold>VEGF</bold>: vascular endothelial growth factor; <bold>ANG1</bold> angiopoietin 1</p></caption><graphic xlink:href="12917_2017_1053_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec20"><title>MSCs derived from omental and subcutaneous adipose tissues have similar immunomodulatory properties</title><p>The gene expression level of IDO was significantly lower in omental MSCs than in subcutaneous cells (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05. Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). The level of IL-10 did not differ significantly between them. Both adipose-derived MSCs prevent CD4+ T cell-proliferation at the same extent (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>MSCs derived from omental and subcutaneous adipose tissues have similar immunomodulatory properties. <bold>a</bold> Quantitative analysis of the mRNAs levels of immunomodulatory factors. Each value was normalized to 18S expression. <bold>b</bold> Quantitative analysis of total CD4+ T-cells stimulated and cultivated with S-MSC CM and O-MSC CM after 5&#x000a0;days. Abbreviations: S-MSCs: mesenchymal stem cells derived from subcutaneous adipose tissue; O-MSCs: mesenchymal stem cells derived from omental adipose tissue; CM: conditioned medium; <bold>IDO</bold> indoleamine-pyrrole 2,3-dioxygenase; <bold>IL-10</bold> interleukin 10</p></caption><graphic xlink:href="12917_2017_1053_Fig5_HTML" id="MO5"/></fig>
</p></sec></sec><sec id="Sec21"><title>Discussion</title><p>A major challenge associated with MSC-based therapies is the selection of the source [<xref ref-type="bibr" rid="CR14">14</xref>]. Here we showed in young and healthy female dogs that, compared to subcutaneous adipose tissue, omental adipose tissue is a more suitable source of MSCs. Since it can be procured from donors with any body condition, its collection procedure is always feasible, its cell yield is high and the MSCs isolated from it have desirable differentiation and paracrine potentials.</p><p>The fact that omental but not subcutaneous adipose tissue was always procurable may be attributed to volume variability of fat depots as well as to the expertise of the professional that procures them. In a study with 1265 dogs, it was shown that the size of collected samples was determined by the location of the adipose tissue, being visceral samples bigger than subcutaneous ones [<xref ref-type="bibr" rid="CR12">12</xref>]. This difference might be critical when donor should be an emaciated patient due to either a chronic or a nutritional disease.</p><p>We showed that omental adipose tissue yielded a higher number of viable MSCs per gram of tissue than subcutaneous adipose tissue. These results are in agreement with other studies showing the same differences in humans [<xref ref-type="bibr" rid="CR14">14</xref>] and dogs [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p><p>Consistent with the results reported for human MSCs, canine MSCs isolated either from omental or subcutaneous adipose tissue followed a lineal trend of proliferation up to passage 12 and senescence characteristics appeared at passage 10 [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Thus, our data support a significant but limited expansion potential of canine MSCs. Hence, the feasibility to be procured and the cell richness of the sample take higher relevance in order to choose the best source of canine MSCs.</p><p>The secretory activity of MSCs favors a regenerative microenvironment [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. The trophic properties of MSCs depend on the secretion of growth factors that induce cell proliferation and migration [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref>]. We showed that canine MSCs isolated from omental or subcutaneous tissues express bFGF, PDGF and HGF. Both bFGF and PDGF elicit target cell proliferation after ligand-binding induction of receptor oligomerization, activation of intrinsic receptor tyrosine kinase and phosphorylation of specific residues in the cytoplasmic region [<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR39">39</xref>]. HGF is a pleiotropic factor displaying mitogenic, motogenic, morphogenetic, and antiapoptotic activities in different target cells [<xref ref-type="bibr" rid="CR40">40</xref>]. Indeed, HGF promotes hepatocytes, keratinocytes, renal tubule cell and endothelial cell proliferation, dissociation of epithelial cell colonies, cell motility, and invasion through extracellular matrix. More recently, it has been shown that bFGF, PDGF and HGF can induce biological responses also on MSCs [<xref ref-type="bibr" rid="CR41">41</xref>&#x02013;<xref ref-type="bibr" rid="CR43">43</xref>]. Our functional studies showed that, irrespective of the source, canine MSCs secrete active mitogenic and motogenic factors.</p><p>Vasculogenesis is a crucial step in the wound healing process [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. The formation of new blood vessels is necessary to sustain the newly formed granulation tissue and the survival of keratinocytes. In this study, we found that adipose tissue derived MSCs express VEGF and ANG1. Both stimulate endothelial cell proliferation, migration, and organization into tubules [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Our functional study showed that MSCs either form omental or subcutaneous tissue secreted active factors that promote vasculogenesis.</p><p>Since in the functional assays we used human fibroblasts or human endothelial cells as target cells, our data prove than trophic and vasculogenic factors secreted by MSCs isolated from dog omental or subcutaneous adipose tissue overcome species-specificity barrier. In order to further characterize the products secreted by canine MSCs it would be relevant to perform the functional experiments using target cells from dogs and other species.</p><p>Much attention has been paid to the immunomodulatory properties of MSCs. Several studies have shown a paracrine suppressive effect on T cells, B cells, monocytes and macrophages [<xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref>]. We showed similar gene expression levels of IL-10 in MSCs from both sources studied. Though, the expression of IDO in MSCs derived from subcutaneous adipose tissue was 11-fold higher than in MSCs derived from omentum. IDO catalyzes the conversion of tryptophan to kynurenine and inhibits T cell proliferation due to tryptophan depletion [<xref ref-type="bibr" rid="CR51">51</xref>]. Nevertheless, this is not the unique mechanism supporting the immunosuppresive potential of MSCs [<xref ref-type="bibr" rid="CR52">52</xref>&#x02013;<xref ref-type="bibr" rid="CR55">55</xref>]. That should explain why, despite of the differences observed in IDO mRNA levels, in the functional assay MSCs from both sources inhibit at the same magnitude CD4+ T cell proliferation. Our results appear consistent with previous findings for human and canine MSCs [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>].</p><p>Data here presented not only shall be useful for evidence based-selection of MSC source but also to expand the frontiers of the use of canine MSCs as they prove to produce active trophic, vasculogenic and immunomodulator soluble factors.</p></sec><sec id="Sec22"><title>Conclusion</title><p>Compared to subcutaneous adipose tissue, omental adipose tissue is a more suitable source of MSCs in dogs. Since it can be procured from donors with any body condition, its collection procedure is always feasible, its cell yield is high and the MSCs isolated from it have desirable differentiation and paracrine potentials.</p></sec></body><back><app-group><app id="App1"><sec id="Sec23"><title>Additional file</title><p>
<media position="anchor" xlink:href="12917_2017_1053_MOESM1_ESM.tif" id="MOESM1"><label>Additional file 1: Table S1.</label><caption><p>Genes, primers and amplicon characteristics. (TIFF 552 kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>ANG1</term><def><p>Angiopoietin 1</p></def></def-item><def-item><term>bFGF</term><def><p>Basic fibroblast growth factor</p></def></def-item><def-item><term>CDPL</term><def><p>Cumulative population doubling level</p></def></def-item><def-item><term>CFU-F</term><def><p>Fibroblastic-like colony forming unit</p></def></def-item><def-item><term>CM</term><def><p>Conditioned medium</p></def></def-item><def-item><term>EDTA</term><def><p>Ethylenediaminetetraacetic acid</p></def></def-item><def-item><term>HGF</term><def><p>Hepatocyte growth factor</p></def></def-item><def-item><term>HUVEC</term><def><p>Human umbilical vein endothelial cells</p></def></def-item><def-item><term>IDO</term><def><p>Indoleamine-pyrrole 2,3-dioxygenase</p></def></def-item><def-item><term>IL-10</term><def><p>Interleukin 10</p></def></def-item><def-item><term>MSCs</term><def><p>Mesenchymal stem cells</p></def></def-item><def-item><term>OM</term><def><p>Omental adipose tissue</p></def></def-item><def-item><term>O-MSCs</term><def><p>Omental mesenchymal stem cells</p></def></def-item><def-item><term>PBS</term><def><p>Phosphate-buffered saline</p></def></def-item><def-item><term>PDGF</term><def><p>Platelet-derived growth factor</p></def></def-item><def-item><term>SC</term><def><p>Subcutaneous adipose tissue</p></def></def-item><def-item><term>S-MSCs</term><def><p>Subcutaneous mesenchymal stem cells</p></def></def-item><def-item><term>VEGF</term><def><p>Vascular endothelial growth factor</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1186/s12917-017-1053-0) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank the dog owners for their disposition to participate in this study. Also, we are grateful with the people that work at the Center of Regenerative Medicine, Facultad de Medicina Clinica Alemana - Universidad del Desarrollo for their technical assistance.</p><p>This study was presented in part as an abstract at the International Society for Stem Cell Research Annual Meeting, Stockholm, june 2015.</p><sec id="FPar1"><title>Funding</title><p>This study was supported by CONICYT Grant No. 21110863 and by CONICYT Doctoral Scholarship to FB.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>All data supporting our findings are included in the manuscript. If readers need additional information they will be provided by the corresponding author (francisca.bahamondes@gmail.com).</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>FB designed the study, performed the experiments, analyzed data and wrote the manuscript. EF and GC participated in animal management and adipose tissue sampling. FBr performed RT-qPCR. PC designed the study, supervised all procedures, analyzed data and revised the manuscript versions. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>Study was approved by Ethic Committee Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile (No. 03&#x02013;2014).</p><p>All dog owners gave written informed consent before animals enter in the study.</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominici</surname><given-names>M</given-names></name><name><surname>Le Blanc</surname><given-names>K</given-names></name><name><surname>Mueller</surname><given-names>I</given-names></name><name><surname>Slaper-Cortenbach</surname><given-names>I</given-names></name><name><surname>Marini</surname><given-names>F</given-names></name><name><surname>Krause</surname><given-names>D</given-names></name><name><surname>Deans</surname><given-names>R</given-names></name><name><surname>Keating</surname><given-names>A</given-names></name><name><surname>Prockop</surname><given-names>DJ</given-names></name><name><surname>Horwitz</surname><given-names>E</given-names></name></person-group><article-title>Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement</article-title><source>Cytotherapy</source><year>2006</year><volume>8</volume><fpage>315</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1080/14653240600855905</pub-id><?supplied-pmid 16923606?><pub-id pub-id-type="pmid">16923606</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Blanc</surname><given-names>K</given-names></name><name><surname>Tammik</surname><given-names>L</given-names></name><name><surname>Sundberg</surname><given-names>B</given-names></name><name><surname>Haynesworth</surname><given-names>SE</given-names></name><name><surname>Ringd&#x000e9;n</surname><given-names>O</given-names></name></person-group><article-title>Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex</article-title><source>Scand J Immunol</source><year>2003</year><volume>57</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3083.2003.01176.x</pub-id><?supplied-pmid 12542793?><pub-id pub-id-type="pmid">12542793</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caplan</surname><given-names>AI</given-names></name><name><surname>Dennis</surname><given-names>JE</given-names></name></person-group><article-title>Mesenchymal stem cells as trophic mediators</article-title><source>J Cell Biochem</source><year>2006</year><volume>98</volume><fpage>1076</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1002/jcb.20886</pub-id><?supplied-pmid 16619257?><pub-id pub-id-type="pmid">16619257</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JW</given-names></name><name><surname>Kang</surname><given-names>KS</given-names></name><name><surname>Koo</surname><given-names>HC</given-names></name><name><surname>Park</surname><given-names>JR</given-names></name><name><surname>Choi</surname><given-names>EW</given-names></name><name><surname>Park</surname><given-names>YH</given-names></name></person-group><article-title>Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells</article-title><source>Stem Cells Dev</source><year>2008</year><volume>17</volume><fpage>681</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1089/scd.2007.0153</pub-id><?supplied-pmid 18717642?><pub-id pub-id-type="pmid">18717642</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Sutton MT, Bonfield TL. Stem cells: innovations in clinical applications. Stem Cells Int. 2014; doi:10.1155/2014/516278.</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuk</surname><given-names>PA</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Ashjian</surname><given-names>P</given-names></name><name><surname>De Ugarte</surname><given-names>DA</given-names></name><name><surname>Huang</surname><given-names>JI</given-names></name><name><surname>Mizuno</surname><given-names>H</given-names></name><name><surname>Alfonso</surname><given-names>ZC</given-names></name><name><surname>Fraser</surname><given-names>JK</given-names></name><name><surname>Benhaim</surname><given-names>P</given-names></name><name><surname>Hedrick</surname><given-names>MH</given-names></name></person-group><article-title>Human adipose tissue is a source of multipotent stem cells</article-title><source>Mol Biol Cell</source><year>2002</year><volume>13</volume><fpage>4279</fpage><lpage>4295</lpage><pub-id pub-id-type="doi">10.1091/mbc.E02-02-0105</pub-id><?supplied-pmid 12475952?><pub-id pub-id-type="pmid">12475952</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strem</surname><given-names>BM</given-names></name><name><surname>Hicok</surname><given-names>KC</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Wulur</surname><given-names>I</given-names></name><name><surname>Alfonso</surname><given-names>Z</given-names></name><name><surname>Schreiber</surname><given-names>RE</given-names></name><name><surname>Fraser</surname><given-names>JK</given-names></name><name><surname>Hedrick</surname><given-names>MH</given-names></name></person-group><article-title>Multipotential differentiation of adipose tissue-derived stem cells</article-title><source>Keio J Med</source><year>2005</year><volume>54</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.2302/kjm.54.132</pub-id><?supplied-pmid 16237275?><pub-id pub-id-type="pmid">16237275</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;812693</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname><given-names>CM</given-names></name><name><surname>Raabe</surname><given-names>O</given-names></name><name><surname>Wenisch</surname><given-names>S</given-names></name><name><surname>Bridger</surname><given-names>PS</given-names></name><name><surname>Kramer</surname><given-names>M</given-names></name><name><surname>Arnhold</surname><given-names>S</given-names></name></person-group><article-title>Isolation, culture and chondrogenic differentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells--a comparative study</article-title><source>Vet Sci Commun</source><year>2012</year><volume>36</volume><fpage>139</fpage><lpage>148</lpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neupane</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>C-C</given-names></name><name><surname>Kiupel</surname><given-names>M</given-names></name><name><surname>Yuzbasiyan-Gurkan</surname><given-names>V</given-names></name></person-group><article-title>Isolation and characterization of canine adipose-derived mesenchymal stem cells</article-title><source>Tissue Eng</source><year>2008</year><volume>14</volume><fpage>1007</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1089/ten.tea.2007.0207</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>N</given-names></name><name><surname>Brandalise</surname><given-names>V</given-names></name><name><surname>Zucconi</surname><given-names>E</given-names></name><name><surname>Secco</surname><given-names>M</given-names></name><name><surname>Strauss</surname><given-names>B</given-names></name><name><surname>Zatz</surname><given-names>M</given-names></name></person-group><article-title>Isolation, characterization, and differentiation potential of canine adipose-derived stem cells</article-title><source>Cell Transplant</source><year>2010</year><volume>9</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.3727/096368909X481764</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astor</surname><given-names>D</given-names></name><name><surname>Hoelzler</surname><given-names>M</given-names></name><name><surname>Harman</surname><given-names>R</given-names></name><name><surname>Bastian</surname><given-names>R</given-names></name></person-group><article-title>Patient factors influencing the concentration of stromal vascular fraction (SVF) for adipose-derived stromal cell (ASC) therapy in dogs</article-title><source>Canine J Vet Res</source><year>2013</year><volume>77</volume><fpage>177</fpage><lpage>182</lpage></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Trzil JE, Masseau I, Webb TL, Chang CH, Dodam JR, Liu H, Quimby JM, Dow SW, Reinero CR. Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study. J Feline Med Surg. 2015; doi:10.1177/1098612X15604351.</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>V</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Belliveau</surname><given-names>P</given-names></name><name><surname>Hamilton</surname><given-names>A</given-names></name><name><surname>Flynn</surname><given-names>LE</given-names></name></person-group><article-title>Comparison of human adipose-derived stem cells isolated from subcutaneous, omental, and intrathoracic adipose tissue depots for regenerative applications</article-title><source>Stem Cells Transl Med</source><year>2014</year><volume>2</volume><fpage>206</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.5966/sctm.2013-0125</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guercio</surname><given-names>A</given-names></name><name><surname>Di Bella</surname><given-names>S</given-names></name><name><surname>Casella</surname><given-names>S</given-names></name><name><surname>Di Marco</surname><given-names>P</given-names></name><name><surname>Russo</surname><given-names>C</given-names></name><name><surname>Piccione</surname><given-names>G</given-names></name></person-group><article-title>Canine mesenchymal stem cells (MSCs): characterization in relation to donor age and adipose tissue-harvesting site</article-title><source>Cell Biol Int</source><year>2013</year><volume>37</volume><fpage>789</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1002/cbin.10090</pub-id><?supplied-pmid 23505013?><pub-id pub-id-type="pmid">23505013</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thengchaisri</surname><given-names>N</given-names></name><name><surname>Wutthiwong</surname><given-names>T</given-names></name><name><surname>Kaewmokul</surname><given-names>S</given-names></name><name><surname>Sastravaha</surname><given-names>A</given-names></name></person-group><article-title>Abdominal obesity is associated with heart disease in dogs</article-title><source>BMC Vet Res</source><year>2014</year><volume>10</volume><fpage>131</fpage><pub-id pub-id-type="doi">10.1186/1746-6148-10-131</pub-id><?supplied-pmid 24923277?><pub-id pub-id-type="pmid">24923277</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobatashi</surname><given-names>T</given-names></name><name><surname>Koie</surname><given-names>H</given-names></name><name><surname>Kusumi</surname><given-names>A</given-names></name><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Kanayama</surname><given-names>K</given-names></name><name><surname>Otsuji</surname><given-names>K</given-names></name></person-group><article-title>Comparative investigation of body composition in male dogs using CT and body fat analysis software</article-title><source>J Vet Med Sci</source><year>2014</year><volume>76</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1292/jvms.13-0397</pub-id><pub-id pub-id-type="pmid">24212506</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Requicha</surname><given-names>JF</given-names></name><name><surname>Viegas</surname><given-names>CA</given-names></name><name><surname>Albuquerque</surname><given-names>CM</given-names></name><name><surname>Azevedo</surname><given-names>JM</given-names></name><name><surname>Reis</surname><given-names>RL</given-names></name><name><surname>Gomes</surname><given-names>ME</given-names></name></person-group><article-title>Effect of anatomical origin and cell passage number on the stemness and osteogenic differentiation potential of canine adipose-derived stem cells</article-title><source>Stem Cell Rev</source><year>2012</year><volume>8</volume><fpage>1211</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1007/s12015-012-9397-0</pub-id><?supplied-pmid 22773405?><pub-id pub-id-type="pmid">22773405</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-G&#x000f3;mez</surname><given-names>I</given-names></name><name><surname>Goldsmith</surname><given-names>H</given-names></name><name><surname>Angulo</surname><given-names>J</given-names></name><name><surname>Prados</surname><given-names>A</given-names></name><name><surname>L&#x000f3;pez-Herv&#x000e1;s</surname><given-names>P</given-names></name><name><surname>Cuevas</surname><given-names>B</given-names></name><name><surname>Dujovny</surname><given-names>M</given-names></name><name><surname>Cuevas</surname><given-names>P</given-names></name></person-group><article-title>Angiogenic capacity of human omental stem cells</article-title><source>Neurogical Res</source><year>2005</year><volume>27</volume><fpage>807</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1179/016164105X63674</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Kleineidam</surname><given-names>B</given-names></name><name><surname>Kleinheinz</surname><given-names>J</given-names></name></person-group><article-title>Regenerative potential of human adipose-derived stromal cells of various origins</article-title><source>J Craniomaxillofac Surg</source><year>2015</year><volume>43</volume><fpage>2144</fpage><lpage>2151</lpage><pub-id pub-id-type="doi">10.1016/j.jcms.2015.10.002</pub-id><?supplied-pmid 26541747?><pub-id pub-id-type="pmid">26541747</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Contador D, Ezquer F, Espinosa M, Arango-Rodriguez M, Puebla C, Sobrevia L, Conget P. Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells. Exp Biol Med (Maywood).&#x000a0;2015;240:1235&#x02013;46.</mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vellasamy</surname><given-names>S</given-names></name><name><surname>Sandrasaigaran</surname><given-names>P</given-names></name><name><surname>Vidyadaran</surname><given-names>S</given-names></name><name><surname>George</surname><given-names>E</given-names></name><name><surname>Ramasamy</surname><given-names>R</given-names></name></person-group><article-title>Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue</article-title><source>World J Stem Cells</source><year>2012</year><volume>4</volume><issue>6</issue><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v4.i6.53</pub-id><?supplied-pmid 22993662?><pub-id pub-id-type="pmid">22993662</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conget</surname><given-names>PA</given-names></name><name><surname>Minguell</surname><given-names>JJ</given-names></name></person-group><article-title>Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells</article-title><source>J Cell Physiol</source><year>1999</year><volume>181</volume><issue>1</issue><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(199910)181:1&#x0003c;67::AID-JCP7&#x0003e;3.0.CO;2-C</pub-id><?supplied-pmid 10457354?><pub-id pub-id-type="pmid">10457354</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">Ezquer FE, Ezquer ME, Simon V, Conget P. The antidiabetic effect of MSCs in not impaired by insulin prophylaxis and is not improved by second dose of cells. PLoS One. 2011; doi:10.1371/journal.pone.0016566.</mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008; doi:10.1371/journal.pone.0002213.</mixed-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x02212;Delta Delta C(T))</article-title><source>Method</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>L</given-names></name><name><surname>Rui</surname><given-names>W</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><name><surname>Qinwan</surname><given-names>W</given-names></name><name><surname>Zhengchao</surname><given-names>N</given-names></name><name><surname>Yongchun</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>M</given-names></name><name><surname>Qiuhui</surname><given-names>P</given-names></name></person-group><article-title>Knochdown of nestin inhibits proliferation and migration of colorectal cancer cells</article-title><source>Int J Clin Exp Pathol</source><year>2015</year><volume>8</volume><fpage>6377</fpage><lpage>6386</lpage><pub-id pub-id-type="pmid">26261513</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponce</surname><given-names>ML</given-names></name></person-group><article-title>Tube formation: an in vitro matrigel angiogenesis assay</article-title><source>Methods Mol Biol</source><year>2009</year><volume>467</volume><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-241-0_10</pub-id><?supplied-pmid 19301671?><pub-id pub-id-type="pmid">19301671</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>KH</given-names></name><name><surname>Jang</surname><given-names>IK</given-names></name><name><surname>Lee</surname><given-names>MW</given-names></name><name><surname>Kim</surname><given-names>HE</given-names></name><name><surname>Yang</surname><given-names>MS</given-names></name><name><surname>Eom</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Yang</surname><given-names>SK</given-names></name><name><surname>Jung</surname><given-names>HL</given-names></name><name><surname>Sung</surname><given-names>KW</given-names></name><name><surname>Kim</surname><given-names>CW</given-names></name><name><surname>Koo</surname><given-names>HH</given-names></name></person-group><article-title>Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues</article-title><source>Cell Immunol</source><year>2009</year><volume>259</volume><fpage>150</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2009.06.010</pub-id><?supplied-pmid 19608159?><pub-id pub-id-type="pmid">19608159</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>HE</given-names></name><name><surname>Somayaji</surname><given-names>S</given-names></name><name><surname>Riley</surname><given-names>F</given-names></name><name><surname>Hoelscher</surname><given-names>GL</given-names></name><name><surname>Norton</surname><given-names>HJ</given-names></name><name><surname>Ingram</surname><given-names>J</given-names></name></person-group><article-title>Human adipose-derived mesenchymal stem cells: serial passaging, doubling time and cell senescence</article-title><source>Biotech Histochem</source><year>2012</year><volume>87</volume><fpage>303</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.3109/10520295.2011.649785</pub-id><?supplied-pmid 22250760?><pub-id pub-id-type="pmid">22250760</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013; doi:10.1038/emm.2013.94.</mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynesworth</surname><given-names>SE</given-names></name><name><surname>Baber</surname><given-names>MA</given-names></name><name><surname>Caplan</surname><given-names>AI</given-names></name></person-group><article-title>Cytokine expression by human marrow-derived mesenchymal progenitor cells <italic>in vitro</italic>: effects of dexamethasone and IL-1 alpha</article-title><source>J Cell Physiol</source><year>1996</year><volume>166</volume><fpage>585</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(199603)166:3&#x0003c;585::AID-JCP13&#x0003e;3.0.CO;2-6</pub-id><?supplied-pmid 8600162?><pub-id pub-id-type="pmid">8600162</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalldijk</surname><given-names>Y</given-names></name><name><surname>Johnson</surname><given-names>AA</given-names></name><name><surname>Ishak</surname><given-names>S</given-names></name><name><surname>Meisel</surname><given-names>HJ</given-names></name><name><surname>Hohaus</surname><given-names>C</given-names></name><name><surname>Stolzing</surname><given-names>A</given-names></name></person-group><article-title>Migrational changes of mesenchymal stem cells in response to cytokine, growth factors, hypoxia and aging</article-title><source>Exp Cell Res</source><year>2015</year><volume>338</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2015.08.019</pub-id><pub-id pub-id-type="pmid">26335540</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilroy</surname><given-names>GE</given-names></name><name><surname>Foster</surname><given-names>SJ</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Ruiz</surname><given-names>J</given-names></name><name><surname>Shrwood</surname><given-names>S</given-names></name><name><surname>Heifetz</surname><given-names>A</given-names></name><name><surname>Ludlow</surname><given-names>JW</given-names></name><name><surname>Stricker</surname><given-names>DM</given-names></name><name><surname>Potiny</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>P</given-names></name><name><surname>Halvorsen</surname><given-names>YD</given-names></name><name><surname>Cheatham</surname><given-names>B</given-names></name><name><surname>Storms</surname><given-names>RW</given-names></name><name><surname>Gimble</surname><given-names>JM</given-names></name></person-group><article-title>Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors</article-title><source>J Cell Physiol</source><year>2007</year><volume>212</volume><issue>3</issue><fpage>702</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1002/jcp.21068</pub-id><?supplied-pmid 17477371?><pub-id pub-id-type="pmid">17477371</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoniades</surname><given-names>H</given-names></name><name><surname>Scher</surname><given-names>C</given-names></name><name><surname>Stiles</surname><given-names>C</given-names></name></person-group><article-title>Purification of human platelet-derived growth factor</article-title><source>Proc Natl Acad Sci U S A</source><year>1979</year><volume>76</volume><fpage>1809</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1073/pnas.76.4.1809</pub-id><?supplied-pmid 287022?><pub-id pub-id-type="pmid">287022</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name><name><surname>Ronnstrand</surname><given-names>L</given-names></name><name><surname>Heldin</surname><given-names>C</given-names></name></person-group><article-title>Biosynthesis and intracellular transport of the receptor for platelet-derived growth factor</article-title><source>Proc Natl Acad Sci U S A</source><year>1987</year><volume>84</volume><fpage>8796</fpage><lpage>8800</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.24.8796</pub-id><?supplied-pmid 2827155?><pub-id pub-id-type="pmid">2827155</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heldin</surname><given-names>C</given-names></name></person-group><article-title>Platelet-derived growth factor--an introduction</article-title><source>Cytokine Growth Factor Rev</source><year>2004</year><volume>15</volume><fpage>195</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2004.03.001</pub-id><?supplied-pmid 15207810?><pub-id pub-id-type="pmid">15207810</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubinus</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Gause</surname><given-names>K</given-names></name><name><surname>LeRoy</surname><given-names>E</given-names></name><name><surname>Trojanowska</surname><given-names>M</given-names></name></person-group><article-title>Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>9822</fpage><lpage>9825</lpage><?supplied-pmid 7511594?><pub-id pub-id-type="pmid">7511594</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>T</given-names></name><name><surname>Moore</surname><given-names>S</given-names></name><name><surname>Lawson</surname><given-names>M</given-names></name><name><surname>Panettieri</surname><given-names>R</given-names></name><name><surname>Chilvers</surname><given-names>E</given-names></name></person-group><article-title>Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation</article-title><source>Mol Pharmacol</source><year>1998</year><volume>54</volume><fpage>1007</fpage><lpage>1015</lpage><?supplied-pmid 9855629?><pub-id pub-id-type="pmid">9855629</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottaro</surname><given-names>DP</given-names></name><name><surname>Rubin</surname><given-names>JS</given-names></name><name><surname>Faletto</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>802</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1126/science.1846706</pub-id><?supplied-pmid 1846706?><pub-id pub-id-type="pmid">1846706</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuldiner</surname><given-names>M</given-names></name><name><surname>Yanuka</surname><given-names>O</given-names></name><name><surname>Itskovitz-Eldor</surname><given-names>J</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name><name><surname>Benvenisty</surname><given-names>N</given-names></name></person-group><article-title>Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>11307</fpage><lpage>11312</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.21.11307</pub-id><?supplied-pmid 11027332?><pub-id pub-id-type="pmid">11027332</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuss</surname><given-names>S</given-names></name><name><surname>Becher</surname><given-names>E</given-names></name><name><surname>Woltje</surname><given-names>M</given-names></name><name><surname>Tietze</surname><given-names>L</given-names></name><name><surname>Jahnen-Dechent</surname><given-names>W</given-names></name></person-group><article-title>Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair and wound healing</article-title><source>Stem Cells</source><year>2004</year><volume>22</volume><fpage>405</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1634/stemcells.22-3-405</pub-id><?supplied-pmid 15153617?><pub-id pub-id-type="pmid">15153617</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forte</surname><given-names>G</given-names></name><name><surname>Minieri</surname><given-names>M</given-names></name><name><surname>Cossa</surname><given-names>P</given-names></name><name><surname>Antenucci</surname><given-names>D</given-names></name><name><surname>Sala</surname><given-names>M</given-names></name><name><surname>Gnocchi</surname><given-names>V</given-names></name><name><surname>Fiaccavento</surname><given-names>R</given-names></name><name><surname>Carotenuto</surname><given-names>F</given-names></name><name><surname>De Vito</surname><given-names>P</given-names></name><name><surname>Baldini</surname><given-names>PM</given-names></name><name><surname>Prat</surname><given-names>M</given-names></name><name><surname>Di Nardo</surname><given-names>P</given-names></name></person-group><article-title>Hepatocyte growth factor effects on Mesenchymal stem cells:proliferation, migration, and differentiation</article-title><source>Stem Cells</source><year>2006</year><volume>24</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2004-0176</pub-id><?supplied-pmid 16100005?><pub-id pub-id-type="pmid">16100005</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>F</given-names></name><name><surname>West</surname><given-names>DC</given-names></name></person-group><article-title>Angiogenesis in wound healing</article-title><source>Pharmacol Ther</source><year>1991</year><volume>52</volume><fpage>407</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/0163-7258(91)90034-J</pub-id><?supplied-pmid 1726477?><pub-id pub-id-type="pmid">1726477</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fam</surname><given-names>NP</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Kutryk</surname><given-names>M</given-names></name><name><surname>Stewart</surname><given-names>DJ</given-names></name></person-group><article-title>Clinician guide to angiogenesis</article-title><source>Circulation</source><year>2003</year><volume>108</volume><fpage>2613</fpage><lpage>2618</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000102939.04279.75</pub-id><?supplied-pmid 14638526?><pub-id pub-id-type="pmid">14638526</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008; doi:10.1371/journal.pone.0001886.</mixed-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pikula</surname><given-names>M</given-names></name><name><surname>Langa</surname><given-names>P</given-names></name><name><surname>Kosikowska</surname><given-names>P</given-names></name><name><surname>Trzonkowski</surname><given-names>P</given-names></name></person-group><article-title>Stem cells and growth factors in wound healing</article-title><source>Postepy Hig Med Dosw</source><year>2015</year><volume>69</volume><fpage>874</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.5604/17322693.1162989</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>A</given-names></name></person-group><article-title>How do mesenchymal stromal cells suppress T cells?</article-title><source>Cell Stem Cell</source><year>2008</year><volume>2</volume><fpage>106</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2008.01.007</pub-id><?supplied-pmid 18371428?><pub-id pub-id-type="pmid">18371428</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Blanc</surname><given-names>K</given-names></name><name><surname>Mougiakakos</surname><given-names>D</given-names></name></person-group><article-title>Multipotent mesenchymal stromal cells and the innate immune system</article-title><source>Nat Rev Immunol</source><year>2012</year><volume>12</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1038/nri3209</pub-id><?supplied-pmid 22531326?><pub-id pub-id-type="pmid">22531326</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>K</given-names></name><name><surname>Mahon</surname><given-names>BP</given-names></name></person-group><article-title>Allogeneic mesenchymal stem cells: agents of immune modulation</article-title><source>J Cell Biochem</source><year>2011</year><volume>112</volume><fpage>1963</fpage><lpage>1968</lpage><pub-id pub-id-type="doi">10.1002/jcb.23119</pub-id><?supplied-pmid 21445861?><pub-id pub-id-type="pmid">21445861</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munn</surname><given-names>DH</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Attwood</surname><given-names>JT</given-names></name><name><surname>Bondarev</surname><given-names>I</given-names></name><name><surname>Conway</surname><given-names>SJ</given-names></name><name><surname>Marshall</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Mellor</surname><given-names>AL</given-names></name></person-group><article-title>Prevention of allogeneic fetal rejection by tryptophan catabolism</article-title><source>Science</source><year>1998</year><volume>281</volume><fpage>1191</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1126/science.281.5380.1191</pub-id><?supplied-pmid 9712583?><pub-id pub-id-type="pmid">9712583</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinnadurai</surname><given-names>R</given-names></name><name><surname>Copland</surname><given-names>IB</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Galipeau</surname><given-names>J</given-names></name></person-group><article-title>IDO-independent suppression of T cell effector function by IFN-&#x003b3;-licensed human mesenchymal stromal cells</article-title><source>J Immunol</source><year>2014</year><volume>192</volume><fpage>1491</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301828</pub-id><?supplied-pmid 24403533?><pub-id pub-id-type="pmid">24403533</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Zhuansun</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ran</surname><given-names>P</given-names></name></person-group><article-title>Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism</article-title><source>Exp Cell Res</source><year>2014</year><volume>15</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2014.03.013</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>DD</given-names></name><name><surname>Centanni</surname><given-names>JM</given-names></name><name><surname>Bhatia</surname><given-names>N</given-names></name><name><surname>Emler</surname><given-names>CA</given-names></name><name><surname>Drier</surname><given-names>D</given-names></name><name><surname>Leverson</surname><given-names>GE</given-names></name><name><surname>McKenna</surname><given-names>DH</given-names><suffix>Jr</suffix></name><name><surname>Gee</surname><given-names>AP</given-names></name><name><surname>Lindblad</surname><given-names>R</given-names></name><name><surname>Hei</surname><given-names>DJ</given-names></name><name><surname>Hematti</surname><given-names>P</given-names></name></person-group><source>Cytotherapy</source><year>2015</year><volume>17</volume><fpage>140</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.jcyt.2014.10.002</pub-id><?supplied-pmid 25455739?><pub-id pub-id-type="pmid">25455739</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selleri</surname><given-names>S</given-names></name><name><surname>Dieng</surname><given-names>MM</given-names></name><name><surname>Nicoletti</surname><given-names>S</given-names></name><name><surname>Louis</surname><given-names>I</given-names></name><name><surname>Beausejour</surname><given-names>C</given-names></name><name><surname>Le Deist</surname><given-names>F</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name></person-group><article-title>Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells</article-title><source>Stem Cells Dev</source><year>2013</year><volume>22</volume><fpage>1063</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1089/scd.2012.0315</pub-id><?supplied-pmid 23167734?><pub-id pub-id-type="pmid">23167734</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Ling</surname><given-names>W</given-names></name><name><surname>L'huillie</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Roberts</surname><given-names>AI</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Rabson</surname><given-names>AB</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression</article-title><source>Stem Cells</source><year>2009</year><volume>27</volume><fpage>1954</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1002/stem.118</pub-id><?supplied-pmid 19544427?><pub-id pub-id-type="pmid">19544427</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>A</given-names></name></person-group><article-title>Cell how do mesenchymal stromal cells suppress T cells?</article-title><source>Stem Cell</source><year>2008</year><volume>2</volume><fpage>106</fpage><lpage>108</lpage></element-citation></ref></ref-list></back></article>